An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer

• Conditions: Esophageal Cancer

• Registration Number: NCT03415815
• Lead Sponsor: Henan Cancer Hospital

Brief Summary

The real-world observational study was designed to explore lymph metastases and prognoses of the Chinese patients with thoracic T1-T3 esophageal cancer

Detailed Description

This trial is a real-world non-interventional observational study. The Chinese patients with thoracic T1-T3 esophageal cancer enrolled from Jan.1999 to Jun.2017 were included and the study data on pathologically diagnosed patient demographic/tumor biological characteristics were collected to evaluate the relevance of lymph metastases and prognoses of the subjects.

Study Timeline

• Study Start: 2017-12-12
• Status Verified: 2018-01
• Study First Submitted: 2018-01-11
• Study First Submitted QC: 2018-01-23
• Last Update Submitted: 2018-01-23
• Study First Posted: 2018-01-30
• Last Update Posted: 2018-01-30
• Primary Completion: 2018-04-30
• Study Completion: 2018-04-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 3673

Inclusion Criteria

• Patients >= 18 years old;
• Patients who received radical resection of esophageal cancer;
• Pathologically diagnosed patients with thoracic T1-T3 esophageal cancer after surgeries;

Exclusion Criteria

• Patients who received upper gastrointestinal surgeries;
• Patients with second primary tumors;

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Numbers of lymph nodes and percentages of patients with surgeries	1999 - 2017	Numbers of lymph nodes and percentages of patients with surgeries in the patients with thoracic T1-T3 esophageal cancer

Secondary Outcome Measures

Name	Time	Method
Impact factors of lymph metastases	1999 - 2017	Impact factors of lymph metastases

Trial Locations

Locations (10)

China-Japan Friendship Hospital; 🇨🇳 Beijing, Beijing, China

China PLA General Hospital; 🇨🇳 Beijing, Beijing, China

Henan cancer hospital; 🇨🇳 Zhengzhou, Henan, China

Tongji Hospital Affiliated to Huazhong Technology Hospital; 🇨🇳 Wuhan, Hubei, China

Jiangsu cancer hospital; 🇨🇳 Nanjing, Jiangsu, China

Xi'an Tangdu Hospital; 🇨🇳 Xi'an, Shaanxi, China

Shanghai Chest Hospital; 🇨🇳 Shanghai, Shanghai, China

Huaxi Hospital Affiliated to Sichuan University; 🇨🇳 Chendu, Sichuan, China

Tianjin Chest Hospital; 🇨🇳 Tianjin, Tianjin, China

First Hospital Affiliated to Zhejiang University; 🇨🇳 Hangzhou, Zhejiang, China